Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.
J Clin Oncol
; 42(3): 253-257, 2024 01 20.
Article
in En
| MEDLINE
| ID: mdl-38011605
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
/
Neoplasms
Limits:
Child
/
Humans
Language:
En
Journal:
J Clin Oncol
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: